Abrocitinib Achieves Early and Complete/Near-Complete Skin Clearance Plus Itch-Free State in Atopic Dermatitis: Phase 3 Pooled Post Hoc Analysis.

Saved in:
Bibliographic Details
Title: Abrocitinib Achieves Early and Complete/Near-Complete Skin Clearance Plus Itch-Free State in Atopic Dermatitis: Phase 3 Pooled Post Hoc Analysis.
Authors: Weidinger S; Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany., Reich K; Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Issa N; Issa Research & Consulting, LLC, Springfield, VA, USA.; Dr. Philip Frost Department of Dermatology & Cutaneous Surgery, University of Miami Miller School of Medicine Miami, Miami, FL, USA.; The Department of Dermatology, The George Washington University School of Medicine & Health Sciences, Washington, DC, USA.; Forefront Dermatology, Vienna, VA, USA., Hong HC; Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada., Bunick CG; Program in Translational Biomedicine, Yale School of Medicine, New Haven, CT, USA.; Department of Dermatology, Yale School of Medicine, New Haven, CT, USA., Biswas P; Pfizer Inc., New York, NY, USA., Chan G; Pfizer, Inc., Groton, CT, USA., Güler E; Pfizer Inc., Istanbul, Turkey., Watkins M; Pfizer Inc., New York, NY, USA., Alderfer J; Pfizer Inc., 500 Arcola Rd, Collegeville, PA, 19426, USA. justine.alderfer@pfizer.com.
Source: Dermatology and therapy [Dermatol Ther (Heidelb)] 2026 Jun 27. Date of Electronic Publication: 2026 Jun 27.
Publication Type: Journal Article
Journal Info: Publisher: Springer Healthcare Communications Country of Publication: Switzerland NLM ID: 101590450 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8210 (Print) NLM ISO Abbreviation: Dermatol Ther (Heidelb)
Database: MEDLINE Ultimate
Description
ISSN:2193-8210
DOI:10.1007/s13555-026-01833-8